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solutionAbstract Different behaviors of catechol, 3-methylcatechol, 3-methoxycatechol, 3,4-dihydroxy-
benz-aldehyde and 3,4-dihydroxybenzoic acid were studied in the presence of 2,3-diaminonaphtha-
lene in the phosphate buffer/acetonitrile solution at room temperature.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Phenazine derivatives are an important class of nitrogen-con-
taining heterocycles which exhibit a wide range of biological
activities. They can be used as anticancer drugs [10], as antimy-
cobacterial agents [11], as promising bioreductive antitumor
agents [9], as potential sensitizers in organic photochemistry
[17] and as drugs for the treatment of tuberculosis [19]. They
are also active against many other mycobacterial infections,
particularly those caused by Mycobacterium leprae [20]. Re-
cently, novel phenazines were developed as promising new
anti-tumor agents [13]. Also, phenazine is an interesting com-
pound and its different properties have been extensively stud-
ied [3]. For example the susceptibility tests against a range of
microbes were carried out by Giddens and his co-worker and
they showed that D-alanylgriseoluteic acid had a broadspectrum of antimicrobial activities and was particularly active
against gram-positive pathogens (Giddens et al., 2007) [2].
Synthesized different phenazinedione derivatives and evalu-
ated the cytotoxicity of the prepared compounds by a SRB as-
say versus doxorubicin. The phenazinedione derivatives
exhibited excellent cytotoxicity toward almost all the human
tumor cell lines tested [10].
In addition, many phenazine compounds are found in nat-
ure and are produced by bacteria [12]. For example Vibrio,
Pelagiobacter, Streptomyces and Pseudomonas produce a
range of phenazine compounds which are different in antibi-
otic properties, depending on the nature and position of side
groups attached to a phenazine nucleus [8].
In continuation of our previous studies on the synthesis of
new heterocyclic and nitrogen-containing compounds ([15] and
2005; [4–7] and 2012), we would like to report the synthesis of
some phenazine derivatives (3a–b) and other products (3c–f)
from the reaction of different catechols (1a–e) with 2,3-diami-
nonaphthalene (2) by K3Fe(CN)6 [14] in the phosphate buffer/
acetonitrile (buffer) solution (50:50) at room temperature
(Scheme 1).
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Scheme 1 Synthesis of 3a–f from 1a–c with 2.
Table 1 Synthesis of 3a–f from the reaction of 1a–e with 2 by K3F
Entry Substrate Product
1 OH
OH
1a
O
O
3a
2
OH
OH
1a
H
N
N
H 3b
3 OH
OH
CH3
1b
N
H
H
N
3c
4 OH
OH
1c
OCH3 NH
HN
NH
NH
3d
5
OH
OH
OHC
1d
HN
NH
OHC
OHC
3e
6
OH
OH
HOOC
1e
NH
NH
HOOC
HOOC
3f
a Isolated yield.
202 D. Habibi et al.2. Experimental
All reagents were purchased from Merck and Aldrich chemical
companies and used without further puriﬁcation. 1H NMR
spectra were recorded on a Bruker Avance DRX 300 MHz
instrument in DMSO. The chemical shifts (d) are reported in
ppm relative to TMS as an internal standard. Mass spectra
were recorded on a Shimadzu GC–MS QP 1100 EX mass spec-
trometer. FT-IR (KBr) spectra were recorded on a Perkin-El-
mer 781 spectrophotometer. Melting points were taken in open
capillary tubes with a BUCHI 510 melting point apparatus ande(CN)6 in buffer solution at room temperature.
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Scheme 3 Proposed mechanism for the synthesis of 3a.
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SIL G/UV 254 plates.
2.1. Typical procedure for the synthesis of 1-methyl-5,12-
dihydrobenzo[b]phenazine-2,3-diol (3c)
To a stirred buffer solution (c= 0.15 M, pH= 7, 60 mL),
were added 2 (1.0 mM) and K3Fe(CN)6 (6.0 mM) [14]. A solu-
tion of 1b (1 mmol) dissolved in buffer (40 mL) was added
dropwise during the period of 15 min at room temperature
after which the solution became dark and precipitated. AcOH
was added to the reaction mixture, the mixture was ﬁltered
after 24 h and the ﬁltrate was extracted with CH2Cl2. The sol-
vent was evaporated and the precipitate was crystallized in ace-
tone and characterized (3c) by IR, 1H NMR and MS.
The residue was not dissolved in any solvent which could be
attributed to the oligomers or polymers of catechols.
The other products were synthesized with the same method
and characterized by the above mentioned techniques.
3. Results and discussion
Different phenazine derivatives (3a–b) and other products (3c–
f) were synthesized from the reaction of different catechols
(1a–e) with 2,3-diaminonaphthalene (2) in the presence of K3-
Fe(CN)6 as an oxidant catalyst [14] in the phosphate buffer/
acetonitrile solution (buffer, 50:50) at room temperature
(Table 1):
3.1. Different products were synthesized as below
3.1.1. Dibenzo[b,e][1,4]dioxine-2,3-diol, C12H8O4 (3a)
Formation of 5,12-dihydrobenzo[b]phenazine-2,3-diol (A,
Scheme 2) was expected from the reaction of the equimolar
amounts of 1a and 2, but formation of 3a showed that one
molecule of 1a reacted as a nucleophile and the other 1a mol-
ecule reacted as an electrophile. Apparently the nucleophilicityScheme 2 Expected compounds frof 1a has dominated the nucleophilicity of 2. The reaction
mechanism is illustrated in Scheme 3 which consists of a dou-
ble nucleophilic attack of one molecule of 1a on the oxidative
form of 1a (stages 2 & 4) [7].
M.p. 157 C; IR (Nujol): 3334, 3083, 1726, 1603, 1270,
1124, 1012, 743 cm1; 1H NMR (300 MHz, DMSO-d6): 7.25
(6H, aromatic), 4.92 (2H, broad, 2OH); mass: 220 (M+ 4)
[1,14,16,18].
3.1.2. 7,14-Dihydrobenzo[2,3-b][1,4]benzodioxino[2,3-
i]phenazine-2,3-diol, C22H14N2O4 (3b)
Since we wanted to prepare 5,12-dihydrobenzo[b]phenazine-
2,3-diol (A in Scheme 2) and we knew that 3a was obtained
from the reaction of equimolar amounts of 1a and 2, we in-
creased the concentration of 2 (2 mmol) in reaction with 1a
(1 mmol) in the presence of K3Fe(CN)6 in the buffer solutionom the reaction of 1a–c with 2.
Scheme 4 Proposed mechanism for the synthesis of 3b.
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was obtained instead of A. Apparently the nucleophilic power
of A is more than 2 in the reaction condition and the reaction
preferred to take place via the attack of A on the other oxida-
tive form of 1a molecule.
The reaction mechanism consists of a nucleophilic attack of
one molecule of 2 on the oxidative form of 1a (Scheme 4) with
the subsequent nucleophilic addition of the obtained product
(stage 6) to another oxidative form of 1a molecule (stage 7) [7].
M.p. 152 C; IR (Nujol): 3390, 3198, 1602, 1524, 1462,
1409, 1377, 1304, 1280, 1185, 1108, 917, 813, 722 cm1; 1H
NMR (300 MHz, DMSO-d6): 7.24 (2H, aromatic), 6.97 (2H,
aromatic), 6.38 (6H, aromatic), 4.10 (4H, broad, NH & OH);
mass: 379 (M+ 9).
The M+ peaks of nitrogen- or oxygen-containing com-
pounds usually show some extra mass units which are more
than the exact molecular masses. It usually depends on the
number of the nitrogen or oxygen in the molecule and is re-
lated to protonation of the quinonic moiety or/and the amino
group [1,14,16,18]. Despite the fact that the 3f molecule does
not have any nitrogen (C12H8O4), its M
+ peak is four units
more than the expected peak which it probably related to the
extra four hydrogen bonded to four oxygen of the molecule
(M+ 4H).
3.1.3. 1-Methyl-5,12-dihydrobenzo[b]phenazine-2,3-diol,
C17H14N2O2 (3c)
3c was prepared from the reaction of 1b (1 mmol) with 2
(1 mmol) in the presence of K3Fe(CN)6 in the buffer solutionat room temperature (Table 1). 3c was the only product which
was in concordance with our expectations. The reaction was
carried out via the attack of 2 on the oxidative form of 1bwhich
is roughly similar to mechanisms illustrated in Scheme 2.
M.p. 162.5 C; IR (Nujol): 3373, 3334, 2954, 2852, 1680,
1600, 1465, 1260, 1140, 840, 780 cm1; 1H NMR (300 MHz,
DMSO-d6): 6.69 (7H, aromatic), 4.11 (4H, broad, NH &
OH), 1.25 (3H, CH3); Mass: 281 (M+ 3) [1,14,16,18].
3.1.4. 4,5-Bis(3-aminonaphthalen-2-ylamino)-3-
methoxybenzene-1,2-diol, C27H24N4O3 (3d)
3d was prepared from the reaction of 1c (1 mmol) with 2
(1 mmol) in the presence of K3Fe(CN)6 in the buffer solution
at room temperature (Table 1). Since the mole ratio of 1c to
2 was 1:1, we expected to obtain 1-methoxy-5,12-dihydro-
benzo[b]phenazine-2,3-diol (B in Scheme 2). Nevertheless for-
mation of 3d shows the simultaneous attack of two
molecules of 2 on one molecule of 1c. The mechanism is
roughly similar to the mechanisms illustrated in Scheme 2.
M.p. 254 C; IR (Nujol): 3425, 3380, 2966, 1720, 1631,
1600, 1512, 1504, 1454, 1288, 1265, 880, 730 cm1; 1H NMR
(300 MHz, DMSO-d6): 7.69 (8H, aromatic), 6.54 (5H, aro-
matic), 6.2 (4H, 2NH2), 4.11 (4H, broad, NH & OH), 3.85
(3H, OCH3); Mass: 452 (M).
3.1.5. 6,60-(Naphthalene-2,3-diylbis(azanediyl))bis(3,4-
dihydroxybenzaldehyde), C24H18N2O6 (3e)
3e was prepared from the reaction of 1d (1 mmol) with 2
(1 mmol) in the presence of K3Fe(CN)6 in the buffer solution
Scheme 5 A plausible mechanism for formation of 3f.
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position in its oxidative form (position 6, Scheme 2), 2 at-
tacked simultaneously on two molecules of 1d. The mechanism
is roughly similar to those explained before.
M.p. 165 C; IR (Nujol): 3360, 3320, 2864, 1728, 1594,
1570, 1463, 1275, 1122, 1072, 762 cm1; 1H NMR (300 MHz,
DMSO-d6): 9.99 (2H, aldehyde), 6.83–7.35 (10H, aromatic),
4.21–4.23 (4H, broad, 4OH), 3.22 (2H, broad, 2NH); mass:
430 (M) [1,14,16,18].
3.1.6. 2-(3-Aminonaphthalen-2-ylamino)-3-(3-(5-carboxy-2,3-
dihydroxyphenylamino)naphthalene-2-ylamino)-4,5-
dihydroxybenzoic acid, C34H26N4O8 (3f)
3f was prepared from the reaction of 1e (1 mmol) with 2
(1 mmol) in the presence of K3Fe(CN)6 in the buffer solution
at room temperature (Table 1). Similar to 1d, also 1e has only
one active position in its oxidative form (position 6, Scheme 2),
so 2 attacked simultaneously on two molecules of 1e, with the
an extra attack of another molecule of 2 on the position 2 of
6,60-(naphthalene-2,3-diylbis(azanediyl)bis(3,4-dihydroxyben-
zoic acid) (Scheme 5).
M.p. 180 C; IR (Nujol): 3370, 3360, 2920, 1724, 1432,
1260, 1087, 1074, 1002, 802, 744 cm1; 1H NMR (300 MHz,
DMSO-d6): 9.98 (2H, acid), 6.60–7.30 (14H, aromatic & 2H,
NH2), 4.29 (4H, broad, 4OH), 3.25 (3H, broad, 3NH); mass:
622 (M+ 4) [1,14,16,18].4. Conclusion
We were able to synthesize some phenazine derivatives (3a–b)
and other products (3c–f) from the reaction of different cate-
chols (1a–e) with 2,3-diaminonaphthalene (2) by K3Fe(CN)6
in the buffer solution (50:50) at room temperature.Acknowledgement
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